AHK-Cu Copper Tripeptide Complex

AHK-Cu (Copper Tripeptide) is a synthetic metallopeptide composed of the amino acid sequence Alanine–Histidine–Lysine complexed with copper ions. This copper-associated peptide is utilized in laboratory investigations focused on vascular signaling, extracellular matrix regulation, and fibroblast-associated cellular processes under controlled experimental conditions.

AHK-Cu is studied for its involvement in copper-dependent biochemical signaling and its interaction with pathways associated with vascular endothelial growth factor (VEGF), extracellular matrix organization, and connective tissue dynamics. Experimental research explores how the peptide–metal complex may influence angiogenic signaling environments, dermal cellular communication, and follicular-associated molecular pathways.

Researchers also investigate AHK-Cu in relation to fibroblast signaling and growth factor–associated molecular regulation. Fibroblasts are widely studied due to their relevance in extracellular matrix structure and collagen-associated processes. The peptide is frequently examined in models evaluating collagen-related signaling, elastin-associated pathways, and redox-sensitive cellular regulation.

In follicular biology research, AHK-Cu is explored in experimental systems studying vascular support signaling, growth cycle regulation, and androgen-associated receptor pathways. Studies may also evaluate molecular responses linked to angiogenesis and extracellular matrix maintenance within follicular microenvironments.

AHK-Cu (100mg) topical formulation is supplied strictly for scientific and laboratory research use only. It is not intended for human consumption, veterinary use, diagnostic procedures, or clinical application.